Isabelle Andrieux‐Meyer
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Hepatitis B Virus Studies, HIV/AIDS Research and Interventions, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission(2019)533 cited
- → Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial(2004)305 cited
- → Safety of efavirenz in the first trimester of pregnancy(2014)273 cited
- → Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy(2013)169 cited
- → Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries(2018)90 cited
- → Disparity in market prices for hepatitis C virus direct-acting drugs(2015)83 cited
- → Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list(2019)60 cited
- → Field Assessment of Generic Antiretroviral Drugs: A Prospective Cohort Study in Cameroon(2005)46 cited
- → Adverse events associated with nevirapine use in pregnancy(2013)36 cited
- → Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial(2021)36 cited